Skip to main content
Caplight Logo









RedC Biotech

RedC Biotech

Private
CaesareaHealthcare & Life Scienceshttps://www.redcbiotech.com/

Last Round

Grant

Mar 22, 2022

Total Funding Raised

$1.9M

Company Overview

RedC Biotech is a biotechnology company developing an industrial process to produce universal red blood cells from stem cells for medical transfusions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

lab-grown bloodsynthetic bloodred blood cellsstem cell therapybioprocessingbioreactorcell cultivationtransfusion medicinebiotechnologyRBCregenerative medicinebiopharmaceuticalcell differentiationblood supplycultivated meat

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RedC Biotech Comparables

Compare RedC Biotech with similar companies based on industry and business-model similarity.

RedC Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Safi Biotherapeutics
86%
KaloCyte, Inc.
77%
HemostOD SA
75%

RedC Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 22, 2022
SeedMay 1, 2020
Pre SeedApr 1, 2018

Key People

Founding team and executive leadership

Ari Gargir

CEO & Founder

Founding Team

RedC Biotech Investors

Notable investors and investment history

RedC Biotech investors
InvestorRounds
Aviram Family FoundationGrant
PipelBizPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 52% MoM.

  • Oct 26, 2024

    Monthly visitors grew 372% MoM, reaching 770.

RedC Biotech Filings

Explore SEC and related filing metadata, where available.

RedC Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RedC Biotech's valuation, stock price, and market status.

Is RedC Biotech a public or private company?

RedC Biotech is a private company.

What is the current stock price of RedC Biotech?

RedC Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is RedC Biotech worth (valuation)?

Valuation information for RedC Biotech is not publicly available.

Can I buy RedC Biotech stock?

RedC Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RedC Biotech's last funding round?

RedC Biotech's most recent funding round was Grant on March 22, 2022.

Who are the main investors in RedC Biotech?

Key investors in RedC Biotech include PipelBiz.

Will RedC Biotech IPO soon?

No public IPO plans have been announced for RedC Biotech.

How can I track RedC Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RedC Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCaesarea
Employee Range4
Year Founded2015
Last FundingMar 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?